AstraZeneca supports crowd sourcing challenge to find new combination therapies for cancer
AstraZeneca is making available preclinical data from over 50 of its medicines as part of...
Sanofi, Fraunhofer create new natural product center of excellence
French pharmaceutical firm Sanofi and Germany-based Fraunhofer-Gesellschaft have formed a natural product center of excellence...
Galena Biopharma, Dr. Reddy’s partner for NeuVax in India
Galena Biopharma and Dr. Reddy's Laboratories have entered into a strategic development and commercialization partnership...
Cellceutix provides updates on clinical trials and developments of Its anti-cancer, anti-psoriasis, and antibiotic...
Cellceutix, a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications,...
Mission Pharmacal introduces new oral spray for dry mouth
US-based pharmaceutical firm Mission Pharmacal has launched a new safe and effective protective oral spray...
Alzheon to advance ALZ-801 into Phase II trial in patients with Alzheimer’s disease
Alzheon announced the launch of the company, the securing of initial private financing, and the...
InnoCore, Allergan to develop new drug delivery products for ophthalmic diseases
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration...
Adimab, Celgene form drug discovery partnership
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use...
Adimab, Innovent collaborate on discovery, commercialization of antibody-based therapeutic
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab...
Supernus to launch Trokendi extended release formulation to treat epilepsy
Specialty pharmaceutical company Supernus Pharmaceuticals is set to launch once-daily extended release formulation of topiramate,...